In Cavite, liberatory harm reduction means building care and justice from the streets up — from mutual aid to drug policy reform, survival practices grow into movements for dignity and change.
The upcoming critical review process offers a chance to de-schedule the coca leaf, mitigating prohibition's environmental and social harms, affirming Indigenous rights, and reforming colonial, punitive drug policies.
On the International Day of the World’s Indigenous Peoples, IDPC's Ann Fordham highlights how the international drug control regime harms Indigenous communities, and how the WHO’s coca leaf review offers a chance to right a longstanding injustice.
For the 2025 Global Day of Action, thousands took action in 262 cities across 80 countries — demanding policies that ensure access to systems of care and support, not punishment.
As panic and geopolitics drive drug and bordering policy, harm reduction advocates find new ground at the UN — mobilising evidence, resisting disinformation, and taking the fight for rights to a global stage.
Indonesia’s drug policy is under review as civil society pushes for health- and rights-based reforms, including legal changes, better treatment access, gender-sensitive harm reduction, and respectful kratom regulation rooted in indigenous knowledge.
In a historic move, the UN CRPD urges Canada to support safe supply and voluntary, rights-based harm reduction. Advocates from the HIV Legal Network call on the government to act, reform drug policy, and uphold disability rights.
Ghada Waly’s resignation offers the UN Secretary-General a chance to appoint a leader who will align UNODC with human rights-based drug policies and the broader UN system.
The INCB’s 2024 report highlights the global failure to ensure equitable access to controlled medicines for pain relief, palliative care, and harm reduction — urging urgent, rights-affirming reforms.
Against a backdrop of global turmoil and multilateral rupture, the 68th session of the CND marked a turning point in the history of global drug policy by deciding to create a panel of independent experts to rethink the global drug control regime.
